Millbrae, CA, United States of America

Mikayel Mkrtichyan

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Augusta, GA (US) (2017)
  • Rockville, MD (US) (2019 - 2020)
  • Millbrae, CA (US) (2018 - 2022)
  • Tujunga, CA (US) (2021 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Groundbreaking Innovations of Mikayel Mkrtichyan

Introduction: Mikayel Mkrtichyan, a prolific inventor based in Millbrae, California, has made significant contributions to the field of biomedical research with a remarkable portfolio of 17 patents. His work primarily focuses on enhancing immune responses, which is crucial in the development of therapies for various diseases.

Latest Patents: Among his latest innovations are antibodies targeting programmed cell death protein 1 (PD-1). These antibodies and their antigen-binding fragments uniquely bind to PD-1, challenging the conventional belief that PD-1 solely promotes immune suppression. Instead, Mkrtichyan's inventions are designed to activate immune cells, thereby promoting proliferation and enhancing cytokine production. Additionally, he has developed cationic lipid vaccine compositions that comprise therapeutic factors and adjuvants. These compositions are aimed at reducing immune suppressor cell populations and augmenting immune responses in mammals, showcasing his dedication to advancing immunotherapy.

Career Highlights: Throughout his career, Mkrtichyan has worked with reputable organizations including the Augusta University Research Institute and PDS Biotechnology Corporation. His roles within these institutions have enabled him to apply his inventive acumen to real-world biomedical challenges.

Collaborations: Mikayel has collaborated with notable colleagues such as Samir N. Khleif and Iryna Lebedyeva. These partnerships have fostered an environment of shared knowledge and innovation, further propelling advancements in the field of immunology.

Conclusion: Mikayel Mkrtichyan's innovative contributions to immunotherapy and vaccine development are paving the way for more effective treatments in the medical field. His 17 patents reflect a deep commitment to understanding and manipulating immune responses, which holds the promise of transforming patient outcomes in various diseases. With ongoing research and collaboration, his work continues to inspire innovation in biomedical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…